CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

β-amyloid (Aβ) plaque accumulation is a hallmark of Alzheimer's disease (AD). It is believed to start many years prior to symptoms and is reflected by reduced cerebrospinal fluid (CSF) levels of the peptide Aβ1–42 (Aβ42). Here we tested the hypothesis that baseline levels of CSF proteins involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, N, Insel, P, Nosheny, R, Zetterberg, H, Trojanowski, J Q, Shaw, L M, Tosun, D, Weiner, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756294/
https://www.ncbi.nlm.nih.gov/pubmed/23962923
http://dx.doi.org/10.1038/tp.2013.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756294/
https://www.ncbi.nlm.nih.gov/pubmed/23962923
http://dx.doi.org/10.1038/tp.2013.69

Ejemplares similares